GERN moving, Okarma speaks soon -
BIO 2003 Sessions
Tuesday, June 24, 2003
Stem Cells and Cloning: Late-Breaking Science and Controversies
Track: Ethics
Time: 2:00 PM - 3:30 PM Room: 202B
Scientific developments, as well as controversies, in stem cell research and nuclear transfer continue. As researchers demonstrate the potential of regenerative medicine, politicians continue to scrutinize this work, and some seek to limit it. This session will examine the scientific, legal and ethical landscape for regenerative medicine.
Chair:
Michael Werner, Vice President, Bioethics, Biotechnology Industry Organization
Speakers:
Thomas B. Okarma, M.D., Ph.D., President & CEO, Geron Corporation
Lawrence Goldstein, Ph.D., Department of Cellular and Molecular Medicine, Howard Hughes Medical Institute, UCSD School of Medicine
Michael Manganiello, Senior Vice President, Government Relations, Coalition for the Advancement of Medical Research